Transient hyperphosphatasemia - Where do we stand?

Turkish Journal of Pediatrics

Volumn 41, Issue 2, 1999, Pages 151-160

  Kutílek, Štépán ^a   Bayer, Milan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alkaline phosphatase; Hyperphosphatasemia

Indexed keywords

ALKALINE PHOSPHATASE; ISOENZYME; VITAMIN D;

BLOOD; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; HUMAN; INFANT; METABOLIC BONE DISEASE; METABOLIC DISORDER; METABOLISM; PRESCHOOL CHILD; PROGNOSIS; REVIEW;

ALKALINE PHOSPHATASE; BONE DISEASES, METABOLIC; CAUSALITY; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; ISOENZYMES; METABOLIC DISEASES; PROGNOSIS; VITAMIN D;

EID: 0033107801     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Whyte MP. Hypophosphatasia: nature's window on alkaline phosphatase function in man. In: Bilezikian JP, Raisz LG, Rodan GA (eds). Principles of Bone Biology. New York: Academic Press; 1996: 951-968.
2. Moss DW. Perspectives in alkaline phosphatase research. Clin Chem 1992; 28: 2486-2492.
3. Bach U. Das Verhalten der alkalischen Serum Phosphatase bei Fruhgeborenen, Rachitikern und Spasmophilen. Z Kinderheilk 1954; 74: 593-609.
4. Guedeke M. Bestaat er hyperphosphatasemia van voorbijgaande aard. Maandschr Kindergeneesk 1972; 40: 46-58.
5. Posen S, Lee C, Vines R, Kilham H, Latham S, Keefe JF. Transient hyperphosphatasemia of infancy-an insufficiently recognized syndrome. Clin Chem 1977; 23: 292-294.
6. Wieme RJ. More on transient hyperphosphatasemia in infancy: an insufficiently recognized syndrome. Clin Chem 1978; 24: 520-522.
7. Stein P, Rosalki SB, Ying Foo A, Hjelm M. Transient hyperphosphatasemia of infancy and early childhood: clinical and biochemical features of 21 cases and literature review. Clin Chem 1987; 33: 313-318.
8. Weiber H, Fex G, Lindberg T, Skude G. Atypical, anodally migrating alkaline phosphatase isoenzyme in children and its relation to abdominal symptoms. Clin Chem 1983; 29: 593-595.
9. Kraut JR, Metrick M, Maxwell NR, Kaplan MM. Isoenzyme studies in transient hyperphosphatasemia of infancy. Am J Dis Child 1985; 139: 736-740.
10. Onica D, Torssander J, Waldenlind L. Recurrent transient hyperphosphatasemia of infancy in an adult. Clin Chem 1992, 38: 1913-1915.
11. Maekawa M, Sugiura K, Azuma Y, Kanno T. Benign transient hyperphosphatasemia in an adult with malignant lymphoma. Clin Chem 1989; 35: 897.
12. Garrote de Marcos JM, Molina Arias M, Echavarri Olvarria F, Arregui Sierra A. Benign transient hyperphosphatasaemia. the contribution of 20 new cases (Spanish). Ann Espan Pediatr 1996; 44: 112-116.
13. Rosalki SB, Hurst NP. Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta 1976; 73: 149-155.
14. Hoshino T, Sasaki M, Watanabe H, Kumasaka K, Kawano K. Studies on transient hyperphosphatasemia (Japanese). Rinsho Byori Jap J Clin Pathol 1990; 38: 81-86.
15. Tanishima K, Ying Q, Hashimoto T, Nagata M, Matsubara F, Miyawaki T. A case of transient hyperphosphatasemia of infancy associated with a probable allergic disorder. Ann Clin Biochem 1991; 28: 519-523.
16. Lachaux A, Chambon M, Boillot, et al. Transient hyperphosphatasemia after liver transplantation in infancy. Transplant P 1996; 28: 2847.
17. Massey GV, Dunn NL, Heckel JL, Chan JC, Russell EC. Benign transient hyperphosphatasemia in children with leukemia and lymphoma. Clin Pediatr 1996; 35: 501-504.
18. Cole DE. Transient hyperphosphatasemia in a child with autosomal recessive vitamin D dependency. Clin Chem 1986; 32: 1418-1419.
19. Crofton PM. What is the cause of benign transient hyperphosphatasemia? Clin Chem 1988; 34: 335-340.
20. Bayer M, Kutilek S, Stepan JJ, Tumova D. Transient hyperphosphatasaemia and malabsorption syndrome. J Paediatr Child H 1996; 32: 197.
21. Kutilek S, Stepan JJ, Bayer M. A case of transient hyperphosphatasemia following vitamin D-deficient rickets. Turk J Pediatr 1993; 35: 205-207.
22. Baildam EM, Mughal MZ, Dalton M, Lewis MA. Transient hyperphosphatasaemia of infancy and failure to thrive. Arch Dis Child 1993; 69: 470-471.
23. De Vito GA. Transient elevation of alkaline phosphatase possibly related to trimethoprimsulfamethoxazole therapy. J Pediatr 1982; 100: 998-999.
24. Bzduch V, Behulova D. Increased acid phosphatase in isolated transient hyperphosphatasemia (Slovak). Cas Lek Ces 1992; 131: 271-272.
25. Kruse K. Normal bone turnover in isolated hyperphosphatasemia. J Pediatr 1985; 106: 946-948.
26. Stepan JJ, Kutilek S, Bayer M. Transient hyperphosphatasemia in infancy associated with an increased urinary hydroxyproline excretion. Clin Chim Acta 1995; 233: 115-118.
27. Kruse K, Reiss I, Inderrieden D, Kutilek S, Acil Y, Agbenu J. Biochemical markers of bone turnover in diseases of extracellular calcium and phosphate metabolism. In: Schonau E (ed). Paediatric Osteology: New Developments in Diagnostics and Therapy. Amsterdam: Elsevier Science; 1996; 203-220.
28. Griffiths J, Vernocchi A, Simoni E. Transient hyperphosphatasemia of infancy and early childhood. A study of serum alkaline phosphatase by electrofocusing techniques. Arch Pathol Lab Med 1995; 119: 784-789.
29. Asanti R, Hultin H, Visakorpi JK. Serum alkaline phosphatase in healthy infants. Occurrence of abnormally high values without known cause. Ann Paediatr Fenn 1966; 12: 139-142.
30. Rang M. The Ulysses syndrome. Can Med Assoc J 1972; 106: 122-123.
31. Frank U, Kruse K. Evidence for infectious origin of isolated transient hyperphosphatasaemia. Eur J Pediatr 1985; 143: 323-324.
32. Kruse K, Kurz N. Further evidence for infectious origin of isolated transient hyperphosphatasaemia. Eur J Pediatr 1989; 148: 453-454.
33. Kraut JR, Shah B. Simultaneous transient hyperphosphatasemia in a set of twins. Am J Dis Child 1989; 143: 881-882.
34. Sanchez Jacob M, Escudero Gutierrez R, Bernardo Fernandez T. Transient hyperphosphatasemia in infancy: two simultaneous cases in twins (Spanish). Ann Espanol Pediatr 1991; 35: 365-366.
35. Nathan E. Transient hyperphosphatasaemia of infancy. Acta Paediatr Scand 1980; 69: 235-238.
36. Holt PA, Steel AE, Armstrong AM. Transient hyperphosphatasemia of infancy following rotavirus infection. J Infection 1984; 9: 283-285.
37. Ng PC, Cheung CK, Tam JS, Li CK. Benign transient hyperphosphatasemia associated with adenovirus infection. J Paediatr Child H 1995; 31: 561-562.
38. Kutilek S, Stepan JJ, Dolezalova P, Kesslerova Z. Transient hyperphosphatasemia of infancy and early childhood-The Ulysses syndrome (Czech). Cas Lek Ces 1989; 128: 375-377.
39. Parfitt AM. Bone remodeling: relationship to the amount and structure of bone and the pathogenesis and prevention of fractures. In: Riggs BL, Melton LJ (eds). Osteoporosis: Etiology, Diagnosis and Management. New York: Raven Press; 1988: 45-93.
40. Lemann J, Gray RW, Maierhofer WJ, Adams ND. Effects of weight loss on serum 1,25 (OH)-Vitamin D concentrations in adults: a preliminary report. Calcif Tissue Int 1984; 36: 139-144.
41. Kumegawa M, Ikeda E, Tanaka S. The effects prostaglandin E, parathyroid hormone, 1,25-dihydroxycholecalciferol and cyclic nucleotide analogs on alkaline phosphatase activity in osteoblastic cells. Calcif Tissue Int 1984; 36: 72-76.
42. Mahy BW, Rowson KE, Parr CW. Studies on the mechanism of action of Riley virus. J Exp Med 1967; 125: 277-288.
43. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulatilon. J Biol Chem 1971; 246: 1461-1467.
44. Wolf PL. The significance of transient hyperphosphatasemia of infancy and childhood to the clinician and clinical pathologist. Arch Patol Lab Med 1995; 119: 774-775.
45. Rosalki SB, Foo AY, Dooley JS. Benign familial hyperphosphatasemia as a cause of unexplained increase in plasma alkaline phosphatase activity. J Clin Pathol 1993; 46: 738-741.
46. Hoshino T. Kumasaka K, Kawano K, Yamagishi F, Sakai H, Komoda T. A case of benign familial hyperphosphatasemia of intestinal origin. Clin Bioch 1993; 26: 421-425.
47. Asami T, Gomi T, Uchiyama M. Persistent non-familial asymptomatic hyperphosphatasaemia: a report on three cases. Acta Paediatr 1995; 84: 346-348.
48. Antoniades K, Karakasis D, Kapetanos G, Lasaridis N, Tzarou V. Chronic idiopathic hyperphosphatasemia. Oral Surg Oral Med O 1993; 76: 200-204.
49. Roth AJ, Abendroth K. Seidel J, Neubert H, Venbrocks R. Management of primary idiopathic hyperphosphatasemia with calcitonin. Int Orthop 1996; 20: 58-60.
50. Kruse K, Schutz C. Calcium metabolism in the Jansen type of metaphyseal dysplasia. Eur J Pediatr 1993; 152: 912-915.
51. Schipani E, Kruse K, Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995; 268: 98-100.
52. Bernulf J, Hall K, Sjogren I, Werner I. Primary hyperparathyroidism in children. Acta Pediatr Scand 1970; 59: 249-258.
53. Goodman WG, Coburn JW, Slatopolsky E, Salusky IB. Renal osteodystrophy in adults and children. In: Favus MJ (ed). Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia: Lippincot-Raven; 1996; 341-360.
54. Sillence DO. Genetic skeletal dsyplasias. In: Behrman RE (ed). Nelson Textbook of Pediatrics. Philadelphia: WB Saunders and Co; 1992. 1731-1746.
55. Leventhal B. Neoplasms and neoplasm-like structures. In: Behrman RE (ed). Nelson Textbook of Pediatrics. Philadelphia: WB Saundes and Co; 1992: 1291-1322.
56. Schonau E, Herzog KH, Bohles HJ. Transient hyperphosphatasaemia of infancy. Eur J Pediatr 1988; 148: 264-266.
57. Kutilek S, Bayer M, Markova D. Prospective follow-up of children with transient hyperphosphatasemia. Clin Pediatr 1997; 36: 491-492.